Lysergic acid diethylamide (LSD) for alcoholism .
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
J Psychopharmacol. 2012 23-Feb;():. 10.1177/0269881112439253Six randomized-controlled trials including a total of 536 patients admitted to alcohol-focused treatment programs were included in this meta-analysis comparing the treatment of alcoholism using a single oral dose of lysergic acid diethylamide (LSD) to any control, including the use of active control up to 50mcg of LSD. The primary outcome was alcohol misuse as systematically measured by interview or self-report at the first reported follow-up. A single dose of LSD had a significant beneficial effect on alcohol misuse at the first reported follow-up assessment.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
